Comments
Loading...

Docebo Analyst Ratings

DCBONASDAQ
Logo brought to you by Benzinga Data
$32.74
At close: May 7 EDT
$32.74
0.000.00%
Pre-Market: 4:00 PM EDT
Q1 2025 earnings tomorrow on Fri May 9th before the market open
Conference call scheduled tomorrow at 8:00 AM Click to view the webcast
Consensus Rating1
Buy
Highest Price Target1
$62.00
Lowest Price Target1
$41.00
Consensus Price Target1
$48.75

Docebo Analyst Ratings and Price Targets | NASDAQ:DCBO | Benzinga

Docebo Inc has a consensus price target of $48.75 based on the ratings of 8 analysts. The high is $62 issued by Craig-Hallum on November 11, 2024. The low is $41 issued by Morgan Stanley on April 16, 2025. The 3 most-recent analyst ratings were released by Morgan Stanley, Needham, and Scotiabank on April 16, 2025, April 10, 2025, and March 4, 2025, respectively. With an average price target of $42.67 between Morgan Stanley, Needham, and Scotiabank, there's an implied 30.32% upside for Docebo Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Nov 24
0
0
0
0
Mar
2
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Morgan Stanley
Needham
Scotiabank
Craig-Hallum
CIBC

1calculated from analyst ratings

Analyst Ratings for Docebo

Buy NowGet Alert
04/16/2025Buy Now25.23%Morgan Stanley
Josh Baer64%
$43 → $41MaintainsOverweightGet Alert
04/10/2025Buy Now28.28%Needham
Ryan MacDonald62%
$42 → $42ReiteratesBuy → BuyGet Alert
03/04/2025Buy Now37.45%Scotiabank
Kevin Krishnaratne38%
$55 → $45MaintainsSector OutperformGet Alert
11/11/2024Buy Now89.37%Craig-Hallum
George Sutton57%
$58 → $62MaintainsBuyGet Alert
11/08/2024Buy Now83.26%Needham
Ryan MacDonald62%
$50 → $60MaintainsBuyGet Alert
10/24/2024Buy Now67.99%Scotiabank
Kevin Krishnaratne38%
$50 → $55MaintainsSector OutperformGet Alert
09/12/2024Buy Now52.72%Needham
Ryan MacDonald62%
$45 → $50MaintainsBuyGet Alert
06/21/2024Buy Now34.39%CIBC
Stephanie Price51%
$53 → $44MaintainsOutperformerGet Alert
06/12/2024Buy Now37.45%Needham
Ryan MacDonald62%
$45 → $45ReiteratesBuy → BuyGet Alert
06/07/2024Buy Now77.15%Craig-Hallum
George Sutton57%
→ $58Initiates → BuyGet Alert
05/16/2024Buy Now37.45%Needham
Ryan MacDonald62%
$45 → $45ReiteratesBuy → BuyGet Alert
05/14/2024Buy Now67.99%Canaccord Genuity
Robert Young35%
$65 → $55MaintainsBuyGet Alert
05/14/2024Buy Now52.72%Scotiabank
Kevin Krishnaratne38%
$65 → $50MaintainsSector OutperformGet Alert
05/13/2024Buy Now61.88%CIBC
Stephanie Price51%
$58 → $53MaintainsOutperformerGet Alert
05/13/2024Buy Now80.21%Morgan Stanley
Josh Baer64%
$65 → $59MaintainsOverweightGet Alert
05/13/2024Buy Now46.61%Goldman Sachs
Kevin Kumar53%
$55 → $48MaintainsNeutralGet Alert
05/13/2024Buy Now37.45%Needham
Ryan MacDonald62%
$63 → $45MaintainsBuyGet Alert
04/19/2024Buy Now98.53%Morgan Stanley
Josh Baer64%
$67 → $65MaintainsOverweightGet Alert
02/26/2024Buy Now67.99%Goldman Sachs
Kevin Kumar53%
$44 → $55MaintainsNeutralGet Alert
02/26/2024Buy Now98.53%Scotiabank
Kevin Krishnaratne38%
$60 → $65MaintainsSector OutperformGet Alert
02/26/2024Buy Now104.64%Morgan Stanley
Josh Baer64%
$63 → $67MaintainsOverweightGet Alert
11/14/2023Buy Now71.04%Needham
Ryan MacDonald62%
→ $56Initiates → BuyGet Alert
11/10/2023Buy Now34.39%Goldman Sachs
Kevin Kumar53%
$39 → $44MaintainsNeutralGet Alert
11/10/2023Buy Now61.88%Morgan Stanley
Josh Jennings61%
$49 → $53MaintainsOverweightGet Alert
08/18/2023Buy Now49.66%Morgan Stanley
Josh Jennings61%
$40 → $49UpgradeEqual-Weight → OverweightGet Alert
08/11/2023Buy Now22.17%Morgan Stanley
Josh Jennings61%
$37 → $40MaintainsEqual-WeightGet Alert
05/22/2023Buy Now13.01%Goldman Sachs
Kevin Kumar53%
→ $37Initiates → NeutralGet Alert
05/12/2023Buy Now13.01%Morgan Stanley
Josh Jennings61%
$39 → $37MaintainsEqual-WeightGet Alert
03/10/2023Buy Now19.12%Morgan Stanley
Josh Jennings61%
$36 → $39MaintainsEqual-WeightGet Alert
03/10/2023Buy Now52.72%Canaccord Genuity
Robert Young35%
$40 → $50MaintainsBuyGet Alert
11/11/2022Buy Now9.96%Morgan Stanley
Josh Baer64%
$40 → $36MaintainsEqual-WeightGet Alert
10/25/2022Buy Now22.17%Morgan Stanley
Josh Baer64%
$44 → $40MaintainsEqual-WeightGet Alert
08/12/2022Buy Now34.39%Morgan Stanley
Josh Baer64%
$41 → $44MaintainsEqual-WeightGet Alert
07/19/2022Buy Now25.23%Morgan Stanley
Josh Baer64%
$43 → $41MaintainsEqual-WeightGet Alert
05/13/2022Buy Now31.34%Morgan Stanley
Josh Baer64%
$54 → $43MaintainsEqual-WeightGet Alert

FAQ

Q

What is the target price for Docebo (DCBO) stock?

A

The latest price target for Docebo (NASDAQ:DCBO) was reported by Morgan Stanley on April 16, 2025. The analyst firm set a price target for $41.00 expecting DCBO to rise to within 12 months (a possible 25.23% upside). 17 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Docebo (DCBO)?

A

The latest analyst rating for Docebo (NASDAQ:DCBO) was provided by Morgan Stanley, and Docebo maintained their overweight rating.

Q

When was the last upgrade for Docebo (DCBO)?

A

The last upgrade for Docebo Inc happened on August 18, 2023 when Morgan Stanley raised their price target to $49. Morgan Stanley previously had an equal-weight for Docebo Inc.

Q

When was the last downgrade for Docebo (DCBO)?

A

There is no last downgrade for Docebo.

Q

When is the next analyst rating going to be posted or updated for Docebo (DCBO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Docebo, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Docebo was filed on April 16, 2025 so you should expect the next rating to be made available sometime around April 16, 2026.

Q

Is the Analyst Rating Docebo (DCBO) correct?

A

While ratings are subjective and will change, the latest Docebo (DCBO) rating was a maintained with a price target of $43.00 to $41.00. The current price Docebo (DCBO) is trading at is $32.74, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.